Document is current
Any future updates will be listed below
-
Authors
Li, Jing
Ge, Jingjing
Chen, Tingting
Cao, Jianghua
He, Xiaohua
Wang, Shulan
Yang, Hang
Wang, Yu
Sun, Peng
Huang, Jiajia
Liu, Shan
Li, Zhiming
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of Guangdong Provience (2023A1515011525)
The Lymphoma Research Fund of China Anti-Cancer Association, and 308-Program for Clinical Research of Sun Yat-sen University Cancer Center (2014-fxy-106 and 2016-fxy-079)
National Natural Science Foundation of China (82073917, 82470185)
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 8 May 2025
First Online: 15 May 2025
Declarations
:
: The study involving human participants was reviewed and approved by the ethics committee of the Sun Yat-sen University Cancer Center (B2023-633–01). This study’s protocol complied with the Declaration of Helsinki. The patients provided written informed consent to participate in this study.
: Not applicable.
: The authors declare no competing interests.
